IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q3 2021 Holdings

Filed 2021-11-05 | 7 holdings | $526.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$152.0K5,524,03128.8%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$140.0K4,962,20226.6%
Pliant Therapeutics, Inc.(PLRX)COM729139105$98.6K5,839,16018.7%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$72.6K2,422,54913.8%
Decibel Therapeutics, Inc.COM24343R106$24.2K3,139,6854.6%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$22.7K3,048,7804.3%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$16.8K6,391,1763.2%